DiaMedica Therapeutics (DMAC) Stock Chart & Stock Price History $3.90 +0.06 (+1.56%) As of 06/30/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DiaMedica Therapeutics Stock Price Performance The DiaMedica Therapeutics (DMAC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 32.20%, with a year-to-date return of -28.18%. In the past month, the stock has decreased 4.88%, reflecting recent market activity. As of the latest close, DiaMedica Therapeutics traded at $3.90 with a market cap of $167.23 million and volume of 174,441 shares. Five years ago, the stock traded at $6.91, representing a 43.56% decrease over that period. At the time, it had a market cap of $98.27 million and a volume of 18,502 shares. Receive DMAC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for DiaMedica Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.36%1 Month Performance-4.88%3 Month Performance+4.00%Year-To-Date Performance-28.18%1 Year Performance+32.20%5 Year Performance-43.56% DMAC Stock Chart for Tuesday, July, 1, 2025 DMAC Chart by TradingView DiaMedica Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/30/2025$3.84$3.90+1.56%$3.99$3.75174,441 shs$167.23 million06/27/2025$3.81$3.84+0.79%$3.94$3.703.18 million shs$164.66 million06/26/2025$3.95$3.81-3.54%$3.98$3.75124,016 shs$163.37 million06/25/2025$3.73$3.95+5.90%$3.95$3.58211,101 shs$169.38 million06/24/2025$3.65$3.73+2.19%$3.94$3.64252,483 shs$159.94 million06/23/2025$3.61$3.65+1.11%$3.82$3.55217,608 shs$156.52 million06/20/2025$3.82$3.61-5.50%$3.96$3.61174,275 shs$154.80 million06/19/2025$3.82$3.82$3.83$3.57125,837 shs$163.80 million06/18/2025$3.57$3.82+7.00%$3.83$3.57125,837 shs$163.80 million06/17/2025$3.51$3.57+1.71%$3.72$3.51122,698 shs$153.09 million Get the Latest News and Ratings for DMAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for DiaMedica Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/16/2025$3.65$3.51-3.84%$4.17$3.51128,940 shs$150.52 million06/13/2025$3.90$3.65-6.41%$3.94$3.65112,709 shs$156.52 million06/12/2025$4.03$3.90-3.23%$4.04$3.8685,686 shs$167.24 million06/11/2025$4.12$4.03-2.18%$4.25$4.0368,588 shs$172.82 million06/10/2025$4.08$4.12+0.98%$4.28$4.0875,483 shs$176.68 million06/09/2025$4.14$4.08-1.45%$4.24$4.06111,635 shs$174.96 million06/06/2025$4.09$4.14+1.22%$4.33$4.02124,071 shs$177.54 million06/05/2025$4.20$4.09-2.62%$4.31$4.07108,165 shs$175.39 million06/04/2025$4.12$4.20+1.94%$4.46$4.15183,684 shs$180.11 million06/03/2025$4.17$4.12-1.20%$4.26$4.05166,026 shs$176.68 million06/02/2025$4.10$4.17+1.71%$4.26$4.0697,855 shs$178.82 million05/30/2025$4.19$4.10-2.15%$4.26$4.0089,854 shs$175.82 million Related Companies Nuvation Bio Stock Price Chart Day One Biopharmaceuticals Stock Price Chart GH Research Stock Price Chart Stoke Therapeutics Stock Price Chart Sana Biotechnology Stock Price Chart Maravai LifeSciences Stock Price Chart Urogen Pharma Stock Price Chart Autolus Therapeutics Stock Price Chart ChromaDex Stock Price Chart Cidara Therapeutics Stock Price Chart Receive DMAC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for DiaMedica Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DMAC) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DiaMedica Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DiaMedica Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
